Whilst cancer is responsible for a large number of deaths in high-income countries the majority of deaths it causes at a global level are in low- and middle-income countries (LMICs). Many of these countries are ill prepared for this as they lack infrastructure, resources (such as manpower and access to surgery, medicines and radiotherapy machines), cancer intelligence systems, and are faced with a higher percentage of patients presenting with advanced disease.
In addition, a large number of people face the concurrent burden of communicable disease. Many of these countries do not have comprehensive universal health coverage. Only 2.7% of global investment in cancer research is spent on research that is directly relevant to LMICs.
The aim of the research and education that I and collaborating colleagues do is to improve cancer outcomes in these settings across the cancer care continuum.